AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 80 of 93

81 4.4.5. Fontan Palliation of Single-Ventricle Physiology COR LOE Recommendations erapeutic (cont'd) 2a C-EO 20. In adults with Fontan circulation and hemodynamically significant stenosis of the Fontan or PAs, catheter-based stenting of the stenosis to reduce Fontan pressure and improve flow is reasonable to improve hemodynamics. 2a C-EO 21. In symptomatic adults with Fontan circulation, or those with evidence of systemic ventricular volume overload, closure of aortopulmonary collaterals to improve symptoms and reduce the likelihood of pathologic ventricular remodeling can be useful. 2b B-R 22. In adults with Fontan circulation, treatment with pulmonary vasodilators may be considered to improve exercise capacity. 2b C-LD 23. In adults with an atriopulmonary Fontan, preserved ventricular function, and acceptable surgical risk with atrial arrhythmias refractory to medical and catheter-based therapies, Fontan conversion surgery may be considered to reduce arrhythmia recurrence. 2b C-EO 24. In adults with Fontan circulation and symptoms or Fontan circulatory failure attributable to significant intracardiac structural or anatomic abnormalities, reoperation may be considered to improve symptoms or reduce the likelihood of progressive Fontan circulatory failure. (cont'd) Table 42. Fontan Palliation: Routine Follow-Up and Testing Intervals Type of Follow-Up or Testing Physiological Stage A* (mo) Physiological Stage B* (mo) Physiological Stage C* (mo) Physiological Stage D* (mo) Outpatient ACHD cardiologist N/A 12 6–12 3–6 Electrocardiogram N/A 12 6–12 6–12 Transthoracic echocardiogram N/A 12 12 6–12 For recommendations about timing of CMR imaging, see Section 4.4.5 supportive text for recommendations #6 and #7. For recommendations about timing of liver imaging, see Section 4.4.5 supportive text for recommendation #2. Modified with permission from Stout et al. Copyright © 2018 American Heart Association, Inc. and American College of Cardiolog y Foundation. * See Section 2.2 for details on the ACHD anatomic and physiological classification system. ACHD indicates adult congenital heart disease; CMR, cardiovascular magnetic resonance; and N/A, not applicable.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease